IA
ANVS icon

IFP Advisors’s Annovis Bio ANVS Stock Holding History

IFP Advisors’s Portfolio ANVS Stock Details ANVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$205 Hold
110
– – ﹤0.01% 4855
2026
Q1 		$245 Sell
110
-100
-48% -$274 ﹤0.01% 4579
2025
Q4 		$727 Hold
210
– – ﹤0.01% 4172
2025
Q3 		$435 Buy
210
+100
+91% +$250 ﹤0.01% 4214
2025
Q2 		$239 Buy
+110
New +$217 ﹤0.01% 4599
2023
Q1 		– Sell
-4,600
Closed -$44K – 3396
2022
Q4 		$44K Hold
4,600
– – ﹤0.01% 2324
2022
Q3 		$44K Buy
4,600
+4,000
+667% +$52.6K ﹤0.01% 2455
2022
Q2 		$6K Hold
600
– – ﹤0.01% 3655
2022
Q1 		$6K Buy
+600
New +$8.67K ﹤0.01% 3655

Other funds holding ANVS

FNT
First National Trust Hermitage, Pennsylvania $2.95B AUM 27.19% 1-Year Est. Return
SG
Sherry Group Mountain Home, Arkansas $102M AUM
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
SIAP
Sterling Investment Advisors (Pennsylvania) Berwyn, Pennsylvania $599M AUM 28.66% 1-Year Est. Return
RSWM
Robertson Stephens Wealth Management San Francisco, California $4.06B AUM 32.22% 1-Year Est. Return
QWM
Quadcap Wealth Management Frisco, Texas $1.03B AUM 28.22% 1-Year Est. Return
KAS
Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return
WSFS
Wilmington Savings Fund Society Wilmington, Delaware $4.48B AUM 24.77% 1-Year Est. Return
GCM
Gallacher Capital Management Lone Tree, Colorado $178M AUM 29.29% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return

IFP Advisors's ANVS Position: Q2 2026 in Review

IFP Advisors held its Annovis Bio (ANVS) position steady in Q2 2026 at 110 shares worth $205. The position accounts for ﹤0.01% of the portfolio, ranked #4855.

IFP Advisors first reported a position in ANVS in Q1 2022 and has held it in 9 quarters since. The position peaked at $44K in Q4 2022. 13 funds tracked by Wall St. Rank hold ANVS as of Q2 2026.

  • IFP Advisors held 110 shares of Annovis Bio worth $205 as of Q2 2026.
  • IFP Advisors left its Annovis Bio share count unchanged in Q2 2026.
  • Annovis Bio made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #4855 holding.
  • IFP Advisors first reported a position in Annovis Bio in Q1 2022 and has held it in 9 quarters since.
  • IFP Advisors's Annovis Bio position peaked at $44K in Q4 2022.
  • 13 funds tracked by Wall St. Rank held Annovis Bio as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.